| WC* | Body Type** | ||||||
| Total | Mean | Underweight1 | Normal2 | Overweight | Obese3 | ||
| Chronic disease status | n (%) | CI (min - max) | n (%) | n (%) | n (%) | n (%) | |
| Men (*ANOVA; F = 10.888, df = 4, p < 0.001, **X2 = 13.909, df = 8, p < 0.05) | |||||||
| No disease | 1912 (65.8) | 95.89 (60 - 145) | 20 (1.0) | 497 (26.0) | 670 (35.0) | 725 (37.9) | |
| Diabetes | 152 (5.2) | 99.25 (79 - 140) | 0 (0.0) | 34 (22.4) | 54 (35.5) | 64 (42.1) | |
| Hypertension | 221 (7.6) | 99.63 (72 - 123) | 0 (0.0) | 44 (19.9) | 79 (35.7) | 98 (44.3) | |
| Cardiovascular Diseases | 166 (5.7) | 96.35 (66 - 123) | 9 (5.4) | 31 (18.7) | 72 (43.4) | 54 (32.5) | |
| Other Diseases | 454 (15.8) | 96.62 (72 - 140) | 1 (0.2) | 105 (23.1) | 161 (35.5) | 187 (41.2) | |
| Women (*ANOVA; F = 55.393, df = 4, p < 0.001, **X2 = 138.693, df = 8, p < 0.001) | |||||||
| No disease | 1394 (65.4) | 82.95 (50 - 115) | 30 (2.2) | 534 (38.3) | 393 (28.2) | 437 (31.3) | |
| Diabetes | 68 (3.2) | 94.24 (69 - 122) | 0 (0.0) | 12 (17.6) | 8 (11.8) | 48 (70.6) | |
| Hypertension | 210 (9.9) | 92.77 (68 - 140) | 0 (0.0) | 32 (15.2) | 38 (18.1) | 140 (66.7) | |
| Cardiovascular Diseases | 74 (3.5) | 87.92 (71 - 110) | 0 (0.0) | 23 (31.1 | 14 (18.9) | 37 (50.0) | |
| Other Diseases | 385 (18.1) | 85.72 (65 - 114) | 0 (0.0) | 131 (34.0) | 108 (28.1) | 146 (37.9) | |
| Total Group (*ANOVA; F = 43.041, df = 4, p < 0.001, **X2 = 93,557, df = 8, p < 0.001) | |||||||
| No disease | 3306 (65.6) | 90.43 (50 - 145) | 50 (1.5) | 1031 (31.2) | 1063 (32.2) | 1162 (35.1) | |
| Diabetes | 220 (4.4) | 97.70 (69 - 140) | 0 (0.0) | 46 (20.9) | 62 (28.2) | 112 (50.9) | |
| Hypertension | 431 (8.6) | 96.29 (68 - 140) | 0 (0.0) | 76 (17.6) | 117 (27.1) | 238 (55.2) | |
| Cardiovascular Diseases | 240 (4.8) | 93.75 (66 - 123) | 9 (3.8) | 54 (22.5) | 86 (35.8) | 91 (37.9) | |
| Other Diseases | 839 (16.7) | 91.62 (65 - 140) | 1 (0.1) | 236 (28.1) | 269 (32.1) | 333 (39.7) | |